Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Visualized Experiments : Jove|June 24, 2024
Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity CycleNicoletta Manduca, Ester Maccafeo, Adele De Ninno, et al.Seminars in Cancer Biology|August 7, 2018
Replication stress response in cancer stem cells as a target for chemotherapyGwenola Manic, Antonella Sistigu, Francesca Corradi, et al.Journal of Visualized Experiments : Jove|May 17, 2021
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor MicroenvironmentsAdele De Ninno, Francesca Romana Bertani, Annamaria Gerardino, et al.Cancers|April 30, 2021
The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 InhibitionLuca Mattiello, Sara Soliman Abdel Rehim, Martina Musella, et al.Oncotarget|March 31, 2016
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancerMaria Buoncervello, Giulia Romagnoli, Mariachiara Buccarelli, et al.Journal of Translational Medicine|November 23, 2023
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancerAntonio Agostini, Ilaria Guerriero, Geny Piro, et al.Cell Death and Differentiation|February 3, 2021
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51Gwenola Manic, Martina Musella, Francesca Corradi, et al.Gut|April 9, 2017
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cellsGwenola Manic, Michele Signore, Antonella Sistigu, et al.Nature Immunology|August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1BMartina Musella, Andrea Guarracino, Nicoletta Manduca, et al.Pageof 2